NCIt definition : An orally bioavailable inhibitor of the c-Met receptor tyrosine kinase with potential
antineoplastic activity. Savolitinib selectively binds to and inhibits the activation
of c-Met in an ATP-competitive manner, and disrupts c-Met signal transduction pathways.
This may result in cell growth inhibition in tumors that overexpress the c-Met protein.
C-Met encodes the hepatocyte growth factor receptor tyrosine kinase and plays an important
role in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis;
this protein is overexpressed or mutated in a variety of cancers.;